A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.
Also called NCT01194154
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 241 participants
- Sponsor
- Registry
-
NCT01194154
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01194154. Randomized; single masking; primary purpose treatment. Start 2010-09-30 (actual); primary completion 2015-03-31 (actual). Results posted on 2016-06-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)
- Condition
- Kidney Disease, Chronic
- Intervention (Drug)
- Methoxy polyethylene glycol-epoetin beta
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hoffmann-La Roche
Record details
- Record id
cardio:ct-nct01194154- Content hash
915dd314675402675e6f6e55594dd7f2b7e093957e4cd7022b36522967b7e959